1. T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity. Issue 1 (December 2017) Authors: Schmid, Daniela; Park, Chun; Hartl, Christina; Subedi, Nikita; Cartwright, Adam; Puerto, Regina; Zheng, Yiran; Maiarana, James; Freeman, Gordon; Wucherpfennig, Kai; Irvine, Darrell; Goldberg, Michael Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes. Issue 1 (December 2018) Authors: Tokatlian, Talar; Kulp, Daniel; Mutafyan, Andrew; Jones, Christopher; Menis, Sergey; Georgeson, Erik; Kubitz, Mike; Zhang, Michael; Melo, Mariane; Silva, Murillo; Yun, Dong; Schief, William; Irvine, Darrell Journal: Scientific reports Issue: Volume 8:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 449 Neoadjuvant cyclic dinucleotides combined with interleukin-2 and anti-PD-1 antibody limit lung metastasis of orthotopic breast tumors through prolonged NK cell activation. (10th December 2020) Authors: Milling, Lauren; Irvine, Darrell Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EXTH-66. ENHANCEMENT OF ANTI-PD-1 THERAPY WITH EXTENDED HALF-LIFE IL-2 IS INDEPENDENT OF MHC CLASS I RESTRICTED ANTIGEN RECOGNITION FOR TREATMENT OF EXPERIMENTAL GLIOMA. (12th November 2021) Authors: Tritz, Zachariah; Ayasoufi, Katayoun; Malo, Courtney; Himes, Benjamin; Khadka, Roman; Fain, Cori; Goddery, Emma; Yokanovich, Lila; Jin, Fang; Hansen, Michael; Parney, Ian; Wang, Chensu; Moynihan, Kelly; Irvine, Darrell; Wittrup, Dane; Johnson, Aaron Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. T lymphocyte engineering with cytokine nanogels for enhanced cancer immunotherapy. Issue 2 (December 2015) Authors: Tang, Li; Zheng, Yiran; Mabardi, Llian; Irvine, Darrell Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Systemic delivery of liposome-anchored anti-CD137 and IL2-Fc prevents lethal toxicity and elicits potent antitumor immunity. Issue 2 (December 2015) Authors: Zhang, Yuan; Irvine, Darrell Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 4308 DEEP-PRIMED IL-15 SUPERAGONIST IMPROVES ANTIVIRAL EFFICACY OF HIV-SPECIFIC CD8+ T-CELLS IN HUMANIZED MOUSE MODEL. Issue Volume 4:Issue(2020)Supplement 1 (June 2020) Authors: McCann, Chase Daniel; Zale, Elizabeth; Ward, Adam; Dilling, Thomas; Danesh, Ali; Stevenson, Eva; Mota, Talia; Boesch, Austin; Andresen, Thomas; Irvine, Darrell; Jones, R. Brad Journal: Journal of clinical and translational science Issue: Volume 4:Issue(2020)Supplement 1 Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Editorial overview: Special section: Immunological engineering. (August 2015) Authors: Irvine, Darrell; Ploegh, Hidde Journal: Current opinion in immunology Issue: Volume 35(2015) Page Start: ix Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗